These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 24254886)

  • 1. Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case-control study.
    Lin KJ; De Caterina R; García Rodríguez LA
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):70-7. PubMed ID: 24254886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention.
    Saini SD; Schoenfeld P; Fendrick AM; Scheiman J
    Arch Intern Med; 2008 Aug; 168(15):1684-90; discussion 1691. PubMed ID: 18695083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleeding.
    González-Pérez A; Sáez ME; Johansson S; Nagy P; García Rodríguez LA
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):215-222. PubMed ID: 27921360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan.
    Nadatani Y; Watanabe T; Tanigawa T; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Yoshiyama M; Arakawa T
    Scand J Gastroenterol; 2013 Mar; 48(3):320-5. PubMed ID: 23298342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation.
    Cea Soriano L; Bueno H; Lanas A; García Rodríguez LA
    Thromb Haemost; 2013 Dec; 110(6):1298-304. PubMed ID: 24008261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry.
    Hira RS; Kennedy K; Nambi V; Jneid H; Alam M; Basra SS; Ho PM; Deswal A; Ballantyne CM; Petersen LA; Virani SS
    J Am Coll Cardiol; 2015 Jan; 65(2):111-21. PubMed ID: 25593051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
    Piazuelo E; Fuentes J; García-González MA; Jiménez P; Lanas A
    Clin Ther; 2008 Jan; 30(1):121-30. PubMed ID: 18343248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Upper and Lower Gastrointestinal Bleeding in New Users of Low-Dose Aspirin.
    Cea Soriano L; Lanas A; Soriano-Gabarró M; García Rodríguez LA
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):887-895.e6. PubMed ID: 29908361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications.
    García Rodríguez LA; Lin KJ; Hernández-Díaz S; Johansson S
    Circulation; 2011 Mar; 123(10):1108-15. PubMed ID: 21357821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention.
    Saini SD; Fendrick AM; Scheiman JM
    Aliment Pharmacol Ther; 2011 Jul; 34(2):243-51. PubMed ID: 21615437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-dose proton pump inhibitor on preventing upper gastrointestinal bleeding in chronic kidney disease patients receiving aspirin.
    Lim H; Kim JH; Baik GH; Park JW; Kang HS; Moon SH; Park CK
    J Gastroenterol Hepatol; 2015 Mar; 30(3):478-84. PubMed ID: 25252119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial infarction and gastro-intestinal bleeding risks associated with aspirin use among elderly individuals with type 2 diabetes.
    Sirois C; Moisan J; Poirier P; Grégoire JP
    Ann Med; 2014 Aug; 46(5):335-40. PubMed ID: 24785356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care.
    Martín Merino E; Johansson S; Nagy P; García Rodríguez LA
    Am J Cardiol; 2013 Oct; 112(8):1075-82. PubMed ID: 23831164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease.
    Ng W; Wong WM; Chen WH; Tse HF; Lee PY; Lai KC; Li SW; Ng M; Lam KF; Cheng X; Lau CP
    World J Gastroenterol; 2006 May; 12(18):2923-7. PubMed ID: 16718820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of upper gastrointestinal bleeding from different drug combinations.
    Masclee GM; Valkhoff VE; Coloma PM; de Ridder M; Romio S; Schuemie MJ; Herings R; Gini R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Kuipers EJ; van der Lei J; Sturkenboom MC
    Gastroenterology; 2014 Oct; 147(4):784-792.e9; quiz e13-4. PubMed ID: 24937265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding.
    Sáez ME; González-Pérez A; Johansson S; Nagy P; García Rodríguez LA
    Am J Cardiovasc Drugs; 2014 Dec; 14(6):443-50. PubMed ID: 25119521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.